Literature DB >> 2432159

Activation of Clostridium botulinum type E toxin purified by two different procedures.

N Yokosawa, K Tsuzuki, B Syuto, K Oguma.   

Abstract

Clostridium botulinum type E toxin was purified from culture supernates and from cell extracts by two methods. The specific activity [2 X 10(4) mouse LD50 (mg protein)-1] of the toxin purified from cell extract under slightly acidic conditions was lower than that [3 X 10(5) LD50 (mg protein)-1] of the toxin purified from culture supernate under slightly alkaline conditions. Both toxin preparations were activated by trypsin treatment, but to different extents, the degree of activation of the toxin from cell extract being about 30-fold higher than that of the toxin from culture supernate. The two toxin preparations had the same electrophoretic mobility on SDS-polyacrylamide gels and antigenic specificity as revealed by agar gel double-immunodiffusion tests. The antigenic specificity of the two toxin preparations was unaltered by trypsin treatment. In SDS-polyacrylamide gel electrophoresis, a single band of Mr 144,000 was demonstrated before trypsin treatment and two bands of Mr 100,000 and 55,000 appeared after trypsin treatment. The two toxin preparations were labelled with 125I and chymotryptic peptide maps were obtained before and after trypsin treatment. The two toxin preparations without trypsin treatment demonstrated many differences in their peptide maps, but the preparations after trypsin activation had similar peptide maps. These results indicate that the toxin obtained from culture fluid was a partially activated form, and that its molecular conformation was different from that of the toxin from cell extract. Differences in specific activity and activation ratio by trypsin treatment may be due to differences in the conformation of the toxin molecules.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2432159     DOI: 10.1099/00221287-132-7-1981

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  7 in total

1.  Botulinum neurotoxin types A, B, and E: fragmentations by autoproteolysis and other mechanisms including by O-phenanthroline-dithiothreitol, and association of the dinucleotides NAD(+)/NADH with the heavy chain of the three neurotoxins.

Authors:  Bibhuti R Dasgupta; Babu S Antharavally; William Tepp; Mary L Evenson
Journal:  Protein J       Date:  2005-08       Impact factor: 2.371

2.  Epitope regions in the heavy chain of Clostridium botulinum type E neurotoxin recognized by monoclonal antibodies.

Authors:  T Kubota; T Watanabe; N Yokosawa; K Tsuzuki; T Indoh; K Moriishi; K Sanda; Y Maki; K Inoue; N Fujii
Journal:  Appl Environ Microbiol       Date:  1997-04       Impact factor: 4.792

3.  Establishment of a monoclonal antibody recognizing an antigenic site common to Clostridium botulinum type B, C1, D, and E toxins and tetanus toxin.

Authors:  K Tsuzuki; N Yokosawa; B Syuto; I Ohishi; N Fujii; K Kimura; K Oguma
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

4.  Simplified purification method for Clostridium botulinum type E toxin.

Authors:  J A Giménez; H Sugiyama
Journal:  Appl Environ Microbiol       Date:  1987-12       Impact factor: 4.792

5.  Development of improved defined media for Clostridium botulinum serotypes A, B, and E.

Authors:  M E Whitmer; E A Johnson
Journal:  Appl Environ Microbiol       Date:  1988-03       Impact factor: 4.792

6.  Membrane Vesicles Derived From Clostridium botulinum and Related Clostridial Species Induce Innate Immune Responses via MyD88/TRIF Signaling in vitro.

Authors:  Nobuhide Kobayashi; Kimihiro Abe; Sachiyo Akagi; Mayu Kitamura; Yoshitake Shiraishi; Aki Yamaguchi; Masahiro Yutani; Sho Amatsu; Takuhiro Matsumura; Nobuhiko Nomura; Noriyuki Ozaki; Nozomu Obana; Yukako Fujinaga
Journal:  Front Microbiol       Date:  2022-02-03       Impact factor: 5.640

7.  Neutralization of Botulinum Neurotoxin Type E by a Humanized Antibody.

Authors:  Yağmur Derman; Katja Selby; Sebastian Miethe; André Frenzel; Yvonne Liu; Christine Rasetti-Escargueil; Arnaud Avril; Thibaut Pelat; Remi Urbain; Alexandre Fontayne; Philippe Thullier; Dorothea Sesardic; Miia Lindström; Michael Hust; Hannu Korkeala
Journal:  Toxins (Basel)       Date:  2016-09-12       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.